An exploratory study examining lipid-lowering medications in reducing fasting serum lipids in schizophrenia patients treated with atypical antipsychotics. [electronic resource]
Producer: 20150413Description: 141-8 p. digitalISSN:- 1547-3325
- Aged
- Antipsychotic Agents -- adverse effects
- Cholesterol, HDL -- blood
- Cholesterol, LDL -- blood
- Female
- Fibric Acids -- therapeutic use
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hyperlipidemias -- chemically induced
- Hypolipidemic Agents -- therapeutic use
- Male
- Middle Aged
- Retrospective Studies
- Schizophrenia -- complications
- Treatment Outcome
- Triglycerides -- blood
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.